Growth Metrics

Medpace Holdings (MEDP) Common Equity (2016 - 2026)

Medpace Holdings filings provide 12 years of Common Equity readings, the most recent being $598.3 million for Q1 2026.

  • On a quarterly basis, Common Equity rose 0.79% to $598.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $598.3 million, a 0.79% increase, with the full-year FY2025 number at $459.1 million, down 44.39% from a year prior.
  • Common Equity hit $598.3 million in Q1 2026 for Medpace Holdings, up from $459.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $881.4 million in Q3 2024 to a low of $172.4 million in Q2 2025.
  • Median Common Equity over the past 5 years was $470.9 million (2023), compared with a mean of $508.9 million.
  • Biggest five-year swings in Common Equity: surged 95.26% in 2024 and later crashed 77.43% in 2025.
  • Medpace Holdings' Common Equity stood at $386.4 million in 2022, then surged by 44.66% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then tumbled by 44.39% to $459.1 million in 2025, then surged by 30.33% to $598.3 million in 2026.
  • The last three reported values for Common Equity were $598.3 million (Q1 2026), $459.1 million (Q4 2025), and $293.6 million (Q3 2025) per Business Quant data.